Cancer treatments often target rapidly dividing cells, which include not only cancer cells but also healthy cells in the bone marrow, digestive tract, and hair follicles. This lack of specificity leads to collateral damage, resulting in toxic side effects. The severity and type of side effects depend on the treatment modality and the individual patient's response.
